论文信息 - Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study - 字舞流文

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

B. Guidet | T. Boulain | F. Philippart | O. Martinet | J. Maizel | M. Feissel | M. Hasselmann | A. Heininger | X. Forceville | J. Poussel | H. van Aken